Annual Total Expenses
$254.76 M
+$118.69 M+87.22%
December 31, 2023
Summary
- As of February 21, 2025, VRDN annual total expenses is $254.76 million, with the most recent change of +$118.69 million (+87.22%) on December 31, 2023.
- During the last 3 years, VRDN annual total expenses has risen by +$213.19 million (+512.87%).
- VRDN annual total expenses is now at all-time high.
Performance
VRDN Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$83.57 M
+$11.31 M+15.65%
September 30, 2024
Summary
- As of February 21, 2025, VRDN quarterly total expenses is $83.57 million, with the most recent change of +$11.31 million (+15.65%) on September 30, 2024.
- Over the past year, VRDN quarterly total expenses has increased by +$32.27 million (+62.91%).
- VRDN quarterly total expenses is now at all-time high.
Performance
VRDN Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
VRDN Total Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +87.2% | +62.9% |
| 3 y3 years | +512.9% | +62.9% |
| 5 y5 years | +514.3% | +62.9% |
VRDN Total Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +208.1% | at high | +220.1% |
| 5 y | 5-year | at high | +512.9% | at high | +1444.7% |
| alltime | all time | at high | +5248.8% | at high | +7596.3% |
Viridian Therapeutics Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $83.57 M(+15.6%) |
| Jun 2024 | - | $72.26 M(+29.1%) |
| Mar 2024 | - | $55.97 M(-21.8%) |
| Dec 2023 | $254.76 M(+87.2%) | $71.55 M(+39.5%) |
| Sep 2023 | - | $51.30 M(-13.6%) |
| Jun 2023 | - | $59.35 M(-18.2%) |
| Mar 2023 | - | $72.57 M(+47.6%) |
| Dec 2022 | $136.08 M(+64.6%) | $49.17 M(+58.7%) |
| Sep 2022 | - | $30.98 M(+3.9%) |
| Jun 2022 | - | $29.82 M(+14.2%) |
| Mar 2022 | - | $26.11 M(-10.9%) |
| Dec 2021 | $82.69 M(+98.9%) | $29.30 M(+104.3%) |
| Sep 2021 | - | $14.34 M(-24.9%) |
| Jun 2021 | - | $19.09 M(-4.4%) |
| Mar 2021 | - | $19.97 M(-4.0%) |
| Dec 2020 | $41.57 M(-10.5%) | $20.79 M(+284.3%) |
| Sep 2020 | - | $5.41 M(-17.3%) |
| Jun 2020 | - | $6.54 M(-25.9%) |
| Mar 2020 | - | $8.83 M(-19.4%) |
| Dec 2019 | $46.44 M(+12.0%) | $10.95 M(-8.2%) |
| Sep 2019 | - | $11.93 M(+4.1%) |
| Jun 2019 | - | $11.46 M(-5.4%) |
| Mar 2019 | - | $12.11 M(+10.8%) |
| Dec 2018 | $41.47 M | $10.93 M(+8.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | $10.10 M(-8.6%) |
| Jun 2018 | - | $11.04 M(+17.4%) |
| Mar 2018 | - | $9.40 M(+24.6%) |
| Dec 2017 | $30.54 M(+134.7%) | $7.55 M(+0.3%) |
| Sep 2017 | - | $7.52 M(-6.8%) |
| Jun 2017 | - | $8.07 M(+9.0%) |
| Mar 2017 | - | $7.40 M(+118.0%) |
| Dec 2016 | $13.01 M(-5.2%) | $3.40 M(+25.5%) |
| Sep 2016 | - | $2.71 M(-19.4%) |
| Jun 2016 | - | $3.36 M(-5.5%) |
| Mar 2016 | - | $3.55 M(-1.7%) |
| Dec 2015 | $13.72 M(+21.6%) | $3.62 M(-0.4%) |
| Sep 2015 | - | $3.63 M(+12.6%) |
| Jun 2015 | - | $3.22 M(-1.0%) |
| Mar 2015 | - | $3.26 M(+8.2%) |
| Dec 2014 | $11.29 M(+137.0%) | $3.01 M(+2.6%) |
| Sep 2014 | - | $2.93 M(-28.2%) |
| Jun 2014 | - | $4.08 M(+224.7%) |
| Mar 2014 | - | $1.26 M(+15.9%) |
| Dec 2013 | $4.76 M(-36.5%) | $1.09 M(-16.2%) |
| Sep 2013 | - | $1.30 M(+11.3%) |
| Jun 2013 | - | $1.16 M(-4.5%) |
| Mar 2013 | - | $1.22 M |
| Dec 2012 | $7.50 M | - |
FAQ
- What is Viridian Therapeutics annual total expenses?
- What is the all time high annual total expenses for Viridian Therapeutics?
- What is Viridian Therapeutics annual total expenses year-on-year change?
- What is Viridian Therapeutics quarterly total expenses?
- What is the all time high quarterly total expenses for Viridian Therapeutics?
- What is Viridian Therapeutics quarterly total expenses year-on-year change?
What is Viridian Therapeutics annual total expenses?
The current annual total expenses of VRDN is $254.76 M
What is the all time high annual total expenses for Viridian Therapeutics?
Viridian Therapeutics all-time high annual total expenses is $254.76 M
What is Viridian Therapeutics annual total expenses year-on-year change?
Over the past year, VRDN annual total expenses has changed by +$118.69 M (+87.22%)
What is Viridian Therapeutics quarterly total expenses?
The current quarterly total expenses of VRDN is $83.57 M
What is the all time high quarterly total expenses for Viridian Therapeutics?
Viridian Therapeutics all-time high quarterly total expenses is $83.57 M
What is Viridian Therapeutics quarterly total expenses year-on-year change?
Over the past year, VRDN quarterly total expenses has changed by +$32.27 M (+62.91%)